PTPRU
Receptor-type tyrosine-protein phosphatase U
Also known as: FMI, hPTP-J, PCP-2, PTP, PTPRO, PTPRU_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92729
- Gene
- PTPRU
- Ensembl
- ENSG00000060656
- Chromosome
- 1
- Canonical length
- 1446 aa
- Protein class
- Enzymes, Plasma proteins, Predicted membrane proteins
OverviewNCBI Gene
The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and two tandem intracellular catalytic domains, and thus represents a receptor-type PTP. The extracellular region contains a meprin-A5 antigen-PTP (MAM) domain, Ig-like and fibronectin type III-like repeats. This PTP was thought to play roles in cell-cell recognition and adhesion. Studies of the similar gene in mice suggested the role of this PTP in early neural development. The expression of this gene was reported to be regulated by phorbol myristate acetate (PMA) or calcium ionophore in Jurkat T lymphoma cells. Alternatively spliced transcript variants have been reported. [provided by RefSeq, Aug 2010]
Canonical amino-acid sequenceUniProt
1446 residues, UniProt reviewed canonical sequence.
>Q92729|PTPRU
1 MARAQALVLA LTFQLCAPET ETPAAGCTFE EASDPAVPCE YSQAQYDDFQ WEQVRIHPGT
61 RAPADLPHGS YLMVNTSQHA PGQRAHVIFQ SLSENDTHCV QFSYFLYSRD GHSPGTLGVY
121 VRVNGGPLGS AVWNMTGSHG RQWHQAELAV STFWPNEYQV LFEALISPDR RGYMGLDDIL
181 LLSYPCAKAP HFSRLGDVEV NAGQNASFQC MAAGRAAEAE RFLLQRQSGA LVPAAGVRHI
241 SHRRFLATFP LAAVSRAEQD LYRCVSQAPR GAGVSNFAEL IVKEPPTPIA PPQLLRAGPT
301 YLIIQLNTNS IIGDGPIVRK EIEYRMARGP WAEVHAVSLQ TYKLWHLDPD TEYEISVLLT
361 RPGDGGTGRP GPPLISRTKC AEPMRAPKGL AFAEIQARQL TLQWEPLGYN VTRCHTYTVS
421 LCYHYTLGSS HNQTIRECVK TEQGVSRYTI KNLLPYRNVH VRLVLTNPEG RKEGKEVTFQ
481 TDEDVPSGIA AESLTFTPLE DMIFLKWEEP QEPNGLITQY EISYQSIESS DPAVNVPGPR
541 RTISKLRNET YHVFSNLHPG TTYLFSVRAR TGKGFGQAAL TEITTNISAP SFDYADMPSP
601 LGESENTITV LLRPAQGRGA PISVYQVIVE EERARRLRRE PGGQDCFPVP LTFEAALARG
661 LVHYFGAELA ASSLPEAMPF TVGDNQTYRG FWNPPLEPRK AYLIYFQAAS HLKGETRLNC
721 IRIARKAACK ESKRPLEVSQ RSEEMGLILG ICAGGLAVLI LLLGAIIVII RKGRDHYAYS
781 YYPKPVNMTK ATVNYRQEKT HMMSAVDRSF TDQSTLQEDE RLGLSFMDTH GYSTRGDQRS
841 GGVTEASSLL GGSPRRPCGR KGSPYHTGQL HPAVRVADLL QHINQMKTAE GYGFKQEYES
901 FFEGWDATKK KDKVKGSRQE PMPAYDRHRV KLHPMLGDPN ADYINANYID GYHRSNHFIA
961 TQGPKPEMVY DFWRMVWQEH CSSIVMITKL VEVGRVKCSR YWPEDSDTYG DIKIMLVKTE
1021 TLAEYVVRTF ALERRGYSAR HEVRQFHFTA WPEHGVPYHA TGLLAFIRRV KASTPPDAGP
1081 IVIHCSAGTG RTGCYIVLDV MLDMAECEGV VDIYNCVKTL CSRRVNMIQT EEQYIFIHDA
1141 ILEACLCGET TIPVSEFKAT YKEMIRIDPQ SNSSQLREEF QTLNSVTPPL DVEECSIALL
1201 PRNRDKNRSM DVLPPDRCLP FLISTDGDSN NYINAALTDS YTRSAAFIVT LHPLQSTTPD
1261 FWRLVYDYGC TSIVMLNQLN QSNSAWPCLQ YWPEPGRQQY GLMEVEFMSG TADEDLVARV
1321 FRVQNISRLQ EGHLLVRHFQ FLRWSAYRDT PDSKKAFLHL LAEVDKWQAE SGDGRTIVHC
1381 LNGGGRSGTF CACATVLEMI RCHNLVDVFF AAKTLRNYKP NMVETMDQYH FCYDVALEYL
1441 EGLESRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTPRU can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- cervix: 27 nTPM
- retina: 17 nTPM
- skeletal muscle: 17 nTPM
- salivary gland: 14 nTPM
- prostate: 13 nTPM
- urinary bladder: 13 nTPM
Single-cell type
- rod photoreceptor cells: 80 nCPM
- salivary duct cells: 67 nCPM
- respiratory basal cells: 61 nCPM
- papillary tip epithelial cells: 52 nCPM
- conjunctival goblet cells: 47 nCPM
- respiratory deuterosomal cells: 43 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 67 nTPM
- midbrain: 49 nTPM
- cerebral cortex: 45 nTPM
- medulla oblongata: 42 nTPM
- basal ganglia: 33 nTPM
- hippocampal formation: 31 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PTPRU.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 290 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Disease | ImmuneIEDB
Conditions an epitope on PTPRU was assayed in.
- melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.34
- gnomAD pLI
- 0.39
- gnomAD missense Z
- 2.45
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- animal organ regeneration
- cell adhesion
- cell surface receptor protein tyrosine phosphatase signaling pathway
- homotypic cell-cell adhesion
- negative regulation of canonical Wnt signaling pathway
- negative regulation of cell migration
- negative regulation of cell population proliferation
- neuron projection development
- positive regulation of cell-cell adhesion mediated by cadherin
- protein dephosphorylation
- protein localization to cell surface
- response to glucocorticoid
- signal transduction
Molecular functions
- beta-catenin binding
- protein tyrosine phosphatase activity
- transmembrane receptor protein tyrosine phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Tyrosine-specific protein phosphatase, PTPase domain
- Tyrosine-specific protein phosphatases domain
- MAM domain
- Protein-tyrosine phosphatase, catalytic
- Fibronectin type III
- Concanavalin A-like lectin/glucanase domain superfamily
- Immunoglobulin-like fold
- Protein-tyrosine phosphatase, active site
- Protein-tyrosine phosphatase-like
- Fibronectin type III superfamily
- Immunoglobulin-like domain superfamily
- Receptor-type Tyrosine-protein Phosphatases
- Receptor-type tyrosine-protein phosphatase U-like, Fn3 domain
- Fibronectin type III domain
- Protein-tyrosine phosphatase
- MAM domain, meprin/A5/mu
- Receptor-type tyrosine-protein phosphatase U Fn3 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTPRU in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTPRU as an antibody target. Whether an autoantibody or antibody against PTPRU could matter depends on whether native PTPRU is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTPRU is annotated at the cell surface, where native PTPRU is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PTPRU as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...